Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL INC | 1,025,014 | reported | 25 Jun 2009 | tx 6−259,372 |
| Bausch Health Companies Inc. | 123,715 | reported | 24 Jun 2022 | tx 9+138,000 |
| REGENXBIO Inc. | 28,861 | reported | 29 May 2026 | tx 38+306,129−102,200 |
| ROCKET PHARMACEUTICALS, INC. | 21,857 | reported | 24 Jun 2015 | tx 6+2,074,037−4,459,658 |
| Vanda Pharmaceuticals Inc. | 15,000 | reported | 16 Jun 2011 | tx 48+3,687,665−15,891,264 |
| HUMAN GENOME SCIENCES INC | 0 | reported | 30 Jul 2012 | tx 26+181,942−165,942 |
| NITROMED INC | 0 | reported | 24 Apr 2009 | tx 16+2,506,533−3,452,928 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | GRANT_AWARD | REGENXBIO Inc. | 9,807 | 0.00 USD | |
| 29 May 2026 | GRANT_AWARD | REGENXBIO Inc. | 46,600 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | REGENXBIO Inc. | 7,768 | 0.00 USD | |
| 30 May 2025 | GRANT_AWARD | REGENXBIO Inc. | 39,815 | 0.00 USD | deriv |
| 01 Oct 2024 | EXERCISE | REGENXBIO Inc. | 10,000 | 3.76 USD | |
| 01 Oct 2024 | SALE | REGENXBIO Inc. | 10,000 | 10.11 USD | |
| 01 Oct 2024 | EXERCISE | REGENXBIO Inc. | 10,000 | 0.00 USD | deriv |
| 03 Sept 2024 | EXERCISE | REGENXBIO Inc. | 10,000 | 3.76 USD | |
| 03 Sept 2024 | SALE | REGENXBIO Inc. | 700 | 12.34 USD | |
| 03 Sept 2024 | SALE | REGENXBIO Inc. | 9,300 | 11.50 USD | |
| 03 Sept 2024 | EXERCISE | REGENXBIO Inc. | 10,000 | 0.00 USD | deriv |
| 01 Aug 2024 | SALE | REGENXBIO Inc. | 400 | 14.59 USD | |
| 01 Aug 2024 | SALE | REGENXBIO Inc. | 9,600 | 13.45 USD | |
| 01 Aug 2024 | EXERCISE | REGENXBIO Inc. | 100 | 12.74 USD | |
| 01 Aug 2024 | EXERCISE | REGENXBIO Inc. | 10,000 | 3.76 USD | |
| 01 Aug 2024 | SALE | REGENXBIO Inc. | 100 | 15.00 USD | |
| 01 Aug 2024 | EXERCISE | REGENXBIO Inc. | 10,000 | 0.00 USD | deriv |
| 01 Aug 2024 | EXERCISE | REGENXBIO Inc. | 100 | 0.00 USD | deriv |
| 29 Jul 2024 | SALE | REGENXBIO Inc. | 11,000 | 15.05 USD | |
| 29 Jul 2024 | EXERCISE | REGENXBIO Inc. | 11,000 | 12.74 USD | |
| 29 Jul 2024 | EXERCISE | REGENXBIO Inc. | 11,000 | 0.00 USD | deriv |
| 01 Jul 2024 | SALE | REGENXBIO Inc. | 10,000 | 11.27 USD | |
| 01 Jul 2024 | EXERCISE | REGENXBIO Inc. | 10,000 | 3.76 USD | |
| 01 Jul 2024 | EXERCISE | REGENXBIO Inc. | 10,000 | 0.00 USD | deriv |
| 31 May 2024 | GRANT_AWARD | REGENXBIO Inc. | 4,790 | 0.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 11 Aug 2016.